Enantioselective pharmacokinetics of homochlorcyclizine. II: Disposition and metabolism of (+)-, (-)- and racemic homochlorcyclizine after oral administration to man. 1992

M Nishikata, and A Nomura, and K Iseki, and K Miyazaki, and A Nakai, and H Fushida, and K Miyake, and T Arita
Faculty of Pharmaceutical Sciences, Mukogawa Women's University, Nishinomiya, Japan.

The pharmacokinetics of a single oral dose of 20 mg (+)-, (-)- and racemic homochlorcyclizine (HCZ) have been studied in humans. The formation of the quarternary ammonium-linked glucuronide was an important metabolic pathway, and the metabolic process was enantioselective as a result of differing urinary excretion rates of (+)-, (-)- and racemic glucuronide. There were significant differences between (+)-, (-)- and racemic HCZ in AUC (0-14 h) and plasma protein binding, but all HCZ enantiomers were slowly absorbed and eliminated (elimination half-lives about 11 h). The results shows help to establish a more efficient dosage regimen for HCZ therapy.

UI MeSH Term Description Entries
D008297 Male Males
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003501 Cyclizine A histamine H1 antagonist given by mouth or parenterally for the control of postoperative and drug-induced vomiting and in motion sickness. (From Martindale, The Extra Pharmacopoeia, 30th ed, p935) Cyclizine HCl,Cyclizine Hydrochloride,Marezine,HCl, Cyclizine,Hydrochloride, Cyclizine
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D005965 Glucuronates Derivatives of GLUCURONIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that include the 6-carboxy glucose structure. Glucosiduronates,Glucuronic Acids,Acids, Glucuronic
D006634 Histamine H1 Antagonists Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. Antihistamines, Classical,Antihistaminics, Classical,Antihistaminics, H1,Histamine H1 Antagonist,Histamine H1 Receptor Antagonist,Histamine H1 Receptor Antagonists,Histamine H1 Receptor Blockaders,Antagonists, Histamine H1,Antagonists, Histamine H1 Receptor,Antihistamines, Sedating,Blockaders, Histamine H1 Receptor,First Generation H1 Antagonists,H1 Receptor Blockaders,Histamine H1 Blockers,Receptor Blockaders, H1,Antagonist, Histamine H1,Classical Antihistamines,Classical Antihistaminics,H1 Antagonist, Histamine,H1 Antagonists, Histamine,H1 Antihistaminics,Sedating Antihistamines
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Nishikata, and A Nomura, and K Iseki, and K Miyazaki, and A Nakai, and H Fushida, and K Miyake, and T Arita
July 1994, The Journal of pharmacy and pharmacology,
M Nishikata, and A Nomura, and K Iseki, and K Miyazaki, and A Nakai, and H Fushida, and K Miyake, and T Arita
September 1994, Biological & pharmaceutical bulletin,
M Nishikata, and A Nomura, and K Iseki, and K Miyazaki, and A Nakai, and H Fushida, and K Miyake, and T Arita
January 2000, British journal of clinical pharmacology,
M Nishikata, and A Nomura, and K Iseki, and K Miyazaki, and A Nakai, and H Fushida, and K Miyake, and T Arita
May 1972, Journal of pharmaceutical sciences,
M Nishikata, and A Nomura, and K Iseki, and K Miyazaki, and A Nakai, and H Fushida, and K Miyake, and T Arita
January 1990, European journal of clinical pharmacology,
M Nishikata, and A Nomura, and K Iseki, and K Miyazaki, and A Nakai, and H Fushida, and K Miyake, and T Arita
January 1981, Drug metabolism and disposition: the biological fate of chemicals,
M Nishikata, and A Nomura, and K Iseki, and K Miyazaki, and A Nakai, and H Fushida, and K Miyake, and T Arita
January 1996, British journal of clinical pharmacology,
M Nishikata, and A Nomura, and K Iseki, and K Miyazaki, and A Nakai, and H Fushida, and K Miyake, and T Arita
June 1982, The Journal of pharmacology and experimental therapeutics,
M Nishikata, and A Nomura, and K Iseki, and K Miyazaki, and A Nakai, and H Fushida, and K Miyake, and T Arita
July 2008, Drug metabolism and disposition: the biological fate of chemicals,
M Nishikata, and A Nomura, and K Iseki, and K Miyazaki, and A Nakai, and H Fushida, and K Miyake, and T Arita
June 1992, The Journal of nutrition,
Copied contents to your clipboard!